FSA Group Limited

As of June 30, 2026, FSA Group Limited carries a market capitalization of 164.46M, placing it among publicly traded companies globally. Its enterprise value stands at 1.20B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

FSA Group Limited's next confirmed earnings release is scheduled for February 25, 2027.

As of June 30, 2026, FSA Group Limited has 122.73M shares outstanding.

As of June 30, 2026, FSA Group Limited trades at a trailing price-to-earnings ratio of 11.40. The price-to-sales ratio is 24.66, and the price-to-book ratio stands at 1.76.

These figures are as of June 30, 2026. The EV/Sales ratio of 183.83 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.20B versus a market cap of 164.46M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, FSA Group Limited maintains a current ratio of 1.71, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 942.89, indicating elevated leverage, while an interest coverage ratio of -0.79 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, FSA Group Limited posted a return on equity (ROE) of 15.65, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) is negative at -3.39, so the business is destroying capital rather than earning a return above its cost of capital. Return on assets (ROA) stands at 1.33, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 5.27, useful for judging operating efficiency across full business cycles. The company generates approximately 67,340.21 in revenue per employee across its workforce of 97.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, FSA Group Limited recorded 7.13M in income tax expense. That works out to an effective tax rate of 29.86, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 23.86M, leaving 14.14M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, FSA Group Limited's stock has gained approximately 0.43% over the past 52 weeks. The 50-day moving average sits at 1.24, while the 200-day moving average is 1.24.

Over the twelve months ended June 30, 2026, FSA Group Limited generated 6.53M in revenue and converted that into 14.14M in net income, yielding earnings per share of 0.14. EBITDA reached -49.50M, while operating income came in at -50.92M.

As of June 30, 2026, FSA Group Limited holds 6.82M in cash and equivalents against 1.03B in total debt, resulting in a net debt position of 1.01B. Total book value stands at 93.30M, with working capital of 8.97M providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The operating margin of -779.58 and net profit margin of 216.43 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, FSA Group Limited paid dividends of 0.08 per share. The dividend payout ratio of 52.04 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -90.34, meaning FSA Group Limited raised more capital through share issuance and new debt than it returned via dividends and buybacks.

FSA Group Limited's most recent stock split took place on June 17, 2002 with a 3:1 split ratio.

As of June 30, 2026, FSA Group Limited has an Altman Z-Score of 0.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.